Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Ono Files Japan Patent Action As Keytruda Nears Market

Executive Summary

Hot on the heels of Keytruda's US approval for first-line use in lung cancer, and just ahead of the drug’s first local launch, rival PD-1 player Ono has launched a patent infringement suit in Japan against Merck, adding to similar actions brought elsewhere by its global Opdivo partner BMS.


Related Content

Japan Keytruda NSCLC Approval Sets Stage For Opdivo Showdown
Japan Drug Cost Concerns Rise To The Top
It’s Here: Merck’s Keytruda Cleared For First-Line Lung Cancer
Japan Approvals Include Keytruda, First Asia Nod for Iclusig


Related Companies